Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2019 Jun 24;7:158. doi: 10.1186/s40425-019-0639-4

Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Noha Abdel-Wahab 1,2, Houssein Safa 3, Ala Abudayyeh 4, Daniel H Johnson 3, Van Anh Trinh 3, Chrystia M Zobniw 3, Heather Lin 5, Michael K Wong 3, Maen Abdelrahim 6, A Osama Gaber 6, Maria E Suarez-Almazor 1,#, Adi Diab 3,✉,#
PMCID: PMC6589871  PMID: 31234936

Correction to: J Immunother Cancer (2019) 7:106

https://doi.org/10.1186/s40425-019-0585-1

Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: ‘We are grateful to Mohsin Shah from the Department of Emergency Medicine at The University of Texas MD Anderson Cancer Center for assisting in study selection, and to Gregory F. Pratt from the Research Medical Library and Erica Goodoff, from the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for their valuable contributions.

Reference

  • 1.Abdel-Wahab N, et al. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer. 2019;7:106. doi: 10.1186/s40425-019-0585-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES